Laryxin Lemon (Chlorhexidine Dihydrochloride, Lidocaine Hydrochloride Monohydrate)

Laryxin Lemon contains chlorhexidine and lidocaine, which act on the oral cavity to reduce microbial load and provide local anaesthesia. It is commonly employed for:

• Oral mucosal antisepsis: reduces bacterial colonisation on gums, tongue and palate.
• Dental procedures: prepares the mouth before extractions, scaling or implant placement.
• Sore throat and ulcer relief: eases pain while limiting infection in pharyngeal or oral lesions.

• Chlorhexidine Dihydrochloride binds to bacterial cell membranes, disrupting integrity and causing leakage of intracellular contents, resulting in broad‑spectrum antimicrobial activity. Lidocaine Hydrochloride Monohydrate blocks voltage‑gated sodium channels in peripheral nerves, preventing depolarisation and producing reversible local anaesthesia on the mucosal surface.

Laryxin Lemon may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

• Altered taste sensation: temporary metallic or bitter taste.
• Oral irritation: mild burning or tingling at the application site.
• Numbness: transient loss of sensation in the mouth.
• Mild erythema: slight redness of the mucosa.
• Dry mouth: reduced salivation.
• Headache: occasional mild headache.

Serious or Rare Side Effects

• Anaphylactic reaction: rapid onset of swelling, hives, or difficulty breathing.
• Stevens‑Johnson syndrome: severe skin and mucosal blistering.
• Persistent ulceration: prolonged mucosal breakdown beyond normal healing.
• Severe hypersensitivity: intense itching, swelling, or rash.
• Cardiovascular effects: rare systemic lidocaine toxicity causing arrhythmia.
• Neurological signs: dizziness or seizures in extreme overdose.

When using Laryxin Lemon, consider the following safety measures:

• Allergy assessment: avoid if known hypersensitivity to chlorhexidine, lidocaine or related compounds.
• Duration of use: limit application to the shortest period necessary to reduce risk of mucosal irritation.
• Age restrictions: avoid routine use in children under six years unless directed by a clinician.
• Concomitant oral products: do not use with other antiseptic mouthwashes containing alcohol or peroxide, which may diminish efficacy.
• Systemic absorption: monitor for signs of lidocaine toxicity if large surface areas are treated.
• Store at room temperature below 25°C: keep in the original container, protect from moisture and direct sunlight.

Laryxin Lemon can interact with other agents applied to the oral cavity or absorbed systemically.

Major Interactions (Avoid)

• Additional topical anesthetics: concurrent use may increase risk of lidocaine toxicity.
• Cationic mouthwashes (e.g., those containing chlorhexidine‑compatible salts): may precipitate and reduce antimicrobial activity.
• Systemic antiarrhythmics: heightened sensitivity to lidocaine effects.

Moderate Interactions (Monitor Closely)

• Alcohol‑based oral rinses: may enhance mucosal irritation.
• Anticoagulants: prolonged mucosal lesions could increase bleeding risk.
• CYP450 substrates: lidocaine is metabolised by CYP3A4; strong inhibitors may raise systemic levels.
• Saliva‑stimulating agents: may dilute the product, reducing local concentration.
• Herbal oral preparations: potential for unpredictable additive effects on mucosa.